UBS Group's stake in Jiangsu Hengrui Pharmaceuticals falls to 4.59%
UBS Group AG's long position in the H-shares of Jiangsu Hengrui Pharmaceuticals Co. Ltd. has decreased to 4.59%, according to a filing with the Hong Kong Stock Exchange (HKEX).
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.